PTEN
25 abstracts
Abstract
Association of germline HSD3B1 (c.1100) genotype with tumoral and clinical outcomes in breast and endometrial cancers.Org: University of South Carolina,
Abstract
Investigation of leptomeningeal disease in high grade glioma and characterization of molecular alterations.Org: Caris Life Sciences, Irving, TX, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Levine Cancer Institute,
Abstract
New ESMO scale for clinical actionability of molecular targets (ESCAT) for gliomas based on a multicentric real world data cohort using next-generation sequencing (NGS).Org: Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain, Hospital Universitario 12 de Octubre, Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d´Hebron Institute of Oncology (VHIO), Institut Catala d'Oncologia Badalona,
Abstract
Liquid-biopsy detection of FGFR2 and other actionable rearrangements in GI malignancies.Org: Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, Englander Institute of Precision Medicine, New York Presbyterian Hospital, Foundation Medicine, Inc., Cambridge, MA, Vanderbilt University Medical Center,
Abstract
Comprehensive profiling of mutational signatures and machine learning and subtypes of homologous recombination deficiency.Org: Genome Insight Inc., Research Institute for Future Medicine, Division of Breast Surgery, Division of Breast and Endocrine Surgery, Samsung Medical Center,
Abstract
Multi-omic characterization of gastrointestinal stromal tumor (GIST) in a large real-world patient cohort.Org: Sylvester Comprehensive Cancer Center, Miami, FL, University of Miami Miller School of Medicine, Miami, FL, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Caris Life Sciences, Irving, TX, Lombardi Comprehensive Cancer Center,
Abstract
The clinical feasibility of circulating tumor DNA alterations in patients with advanced hepatocellular carcinoma.Org: Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, CHA Bundang Medical Center, CHA University School of Medicine, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, Medical Oncology Group,
Abstract
Genetic ancestry associations with somatic mutations in a real-world cohort of over 3,000 patients with prostate cancer.Org: Tempus Labs, Inc., Tempus AI, University of Southern California Marshall School of Business,
Abstract
Real-world genetic testing patterns in metastatic prostate cancer in Latin American (LATAM) population.Org: Instituto Alexander Fleming, Fundación Cancer - Fuca, Hospital Italiano de Buenos Aires, Sociedad de Oncología y Hematología del Cesar SOHEC, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru,
Abstract
Disparities in minority patients with breast cancer under 40 years of age: A single center experience.Org: UT Austin Dell Medical School, Ascension Seton,
Abstract
Comprehensive genomic profiling of Taiwanese patients with breast cancer using a novel targeted panel: Preliminary analyses from a prospective triple-negative cohort.Org: Taipei Veterans General Hospital, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy,
Abstract
Validation of a breast cancer polygenic risk score in 15,490 Brazilians using exome sequencing.Org: Mendelics, Instituto D’Or de Pesquisa e Ensino (IDOR), Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, IL, The University of Chicago Medicine Center for Advanced Care at Orland Park, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL,
Abstract
Commercial next generation sequencing in a real-world cohort of patients with metastatic breast cancer.Org: Renaissance School of Medicine at Stony Brook University, Stony Brook University Hospital - Cancer Center,
Abstract
Effect of somatic-germline genomic integration on the contribution of pathogenic germline genetic variants (gPV) to colorectal cancer (CRC) carcinogenesis.Org: Memorial Sloan Kettering Cancer Center, New York, NY, Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY,
Abstract
Prevalence and characteristics analysis of CDKN2A/B deletion in glioma.Org: Huashan Hospital Fudan University, Shanghai Medical College, Fudan University, Fudan University (Xiamen Branch), Shanghai, China, Gracell Biotechnologies, Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd.,
Abstract
A pilot study evaluating somatic mutational burden and signatures among endometrial cancer patients: Is there prognostic benefit to whole genome sequencing?Org: Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, New York Oncology Hematology PC, Nykode Therapeutics, Cornell University, Morehouse School of Medicine,
Abstract
Molecular profile of SWI/SNF complex in Chinese patients with ovarian cancer.Org: Nanjing Simcere Medical Laboratory Science Co., Ltd Nanjing, China, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China,
Abstract
Somatic hereditary gene panel analysis: A pilot study from Uzbekistan.Org: Vita Alliance Hospital, Tashkent, Uzbekistan,
Abstract
Prevalence of pathogenic variants in non-BRCA genes and their impact on clinical practice in Argentina.Org: Hospital Privado Universitario de Córdoba, CIMETSA-IUCBC,
Abstract
Homologous recombination-related (HRR) gene mutations in patients with glioma and their relevance to genomic characteristics, tumor mutation burden (TMB), and prognosis.Org: Jinan, China, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China,
Abstract
Mutation profiling of gliomas based on sex, age, and family history.Org: Shenzhen Longgang Third People's Hospital, Shenzhen, China, Haplox biotechnology Co., Ltd., Shenzhen, Guangdong, China, HaploX Biottechnology Co., Ltd., Shenzhen, Guangdong, China, HaploX Biotechnology, Shenzhen, China, HaploX Biotechnology Co., Ltd, Shenzhen, Guangdong, China, Tianjin Union Medical Center, Tianjin, Tianjin, China, Shenzhen, Guangdong, China, HaploX Biotechnology, Shenzhen, China,
Abstract
Clinical and genomic characteristics between DDR germline and somatic mutations in pan-cancer.Org: Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China,
Abstract
Spectrum of germline pathogenic variants among patients with cancer in Mexico.Org: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico, National Institute of Medical Sciences and Nutrition Salvador Zubirán, City of Hope National Medical Center, Latin American School of Oncology,
Abstract
A survey on the detection of HPD-related genes by liquid biopsy in patients with lung cancer in China.Org: Tianjin Medical University General Hospital, Tianjin, China, HaploX Biotechnology, Shenzhen, China, HaploX Biotechnology Co. Ltd.,
Abstract
Comprehensive analysis of the mutational status of early colon cancer: Real world data from the AIO ColoPredict registry study.Org: Institut für Pathologie, Georgius Agricola Stiftung Ruhr, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, Winship Cancer Institute of Emory University, Atlanta, GA, Emory University, Atlanta, GA, Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, Department of Medicine, Massachusetts General Hospital, Boston, MA, Department of Medicine, Emory University School of Medicine, Atlanta, GA, Department of Urology, Emory University School of Medicine, Atlanta, GA, Oncology and Palliative Care Units, Ruhr-University Bochum,